InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Bausch Health Companies Inc.

BHC Clue Score44
Quebec, Canada Fiscal year ends December CIK 0000885590 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

23
Insider
Date
Role
Action
Shares
Price
Amount
Frank D. Lee
21 Aug 2025
Director
Sell
15,912
$7.66
$121.89K
Seana Carson
28 Feb 2023
EVP, General Counsel
Sell
292
$9.32
$2.72K
Robert Spurr
14 Apr 2022
U.S. President-Pharma Business
Sell
1,595
$22.19
$35.39K
Robert Spurr
15 Mar 2022
U.S. President-Pharma Business
Sell
4,846
$22.20
$107.58K
Joseph F Gordon
8 Mar 2022
Pres&Co-Head Bausch&Lomb/Int'l
Sell
3,889
$21.76
$84.62K
Robert Spurr
2 Mar 2022
U.S. President-Pharma Business
Sell
1,595
$23.37
$37.28K
Joseph F Gordon
2 Mar 2022
Pres&Co-Head Bausch&Lomb/Int'l
Sell
11,077
$23.37
$258.87K
Joseph F Gordon
1 Mar 2022
Pres&Co-Head Bausch&Lomb/Int'l
Sell
6,338
$23.82
$150.97K
Robert Spurr
15 Feb 2022
U.S. President-Pharma Business
Sell
3,251
$25.02
$81.34K
Robert Spurr
18 Jan 2022
U.S. President-Pharma Business
Sell
3,251
$26.63
$86.57K
Sam Eldessouky
11 Jun 2021
EVP & Chief Financial Officer
Sell
17,000
$31.68
$538.59K
Amy B Wechsler
26 May 2021
Director
Sell
11,037
$31.79
$350.81K
William D. Humphries
8 Sep 2020
President, Ortho-Dermatologics
Sell
5,667
$16.17
$91.64K
ValueAct Holdings, L.P.
5 Jun 2020
Director
Sell indirect
948,353
$19.24
$18.25M
Mark C. McKenna
19 Aug 2019
President, Salix
Sell
10,773
$21.83
$235.22K
Christina Ackermann
12 Aug 2019
EVP and General Counsel
Sell
3,418
$22.45
$76.73K
Christina Ackermann
11 Jul 2019
EVP and General Counsel
Sell
3,968
$24.81
$98.45K
Christina Ackermann
16 Oct 2018
EVP and General Counsel
Sell
4,542
$25.50
$115.82K
Christina Ackermann
15 Oct 2018
EVP and General Counsel
Sell
15,404
$24.83
$382.48K
John Paulson
6 Mar 2018
Director
Sell indirect
7,066,629
$15.40
$108.83M
John Paulson
16 Nov 2017
Director
Sell indirect
344,216
$14.39
$4.95M
Pershing Square Capital Management, L.P.
13 Mar 2017
Director
Sell indirect
18,114,432
$11.00
$199.26M
Pershing Square Capital Management, L.P.
12 Dec 2016
Director
Sell indirect
3,476,690
$14.85
$51.63M
Show all 97 transactions →

What was left out

Form 4 filings counted 539
Amendments (4/A) skipped 22
Filings about a different issuer 2
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 5
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 18,345,887
Sales filed before the plan box existed 22
History held since 5 Jan 2010